Medicare GLP-1 coverage starts Wednesday. Here’s what patients should know about cost, eligibility a

LOUISVILLE, Ky.--(BUSINESS WIRE)--The Humana Foundation, the philanthropic arm of Humana Inc. (NYSE:

O'Reilly's extensive experience across healthcare compliance, risk management, regulatory oversight

CenterWell's rapid growth is helping HUM expand beyond insurance with integrated care, acquisitions,

Swedish care provider Ambea said on Monday it had made a recommended public ​offer for peer Humana ,

This whale alert can help traders discover the next big trading opportunities. Whales are entities w

B of A Securities analyst Kevin Fischbeck maintains Humana (NYSE:HUM) with a Neutral and raises t

Evercore ISI Group analyst Elizabeth Suzuki maintains Humana (NYSE:HUM) with a In-Line and raises

Federal investigators found Medicare Advantage plans frequently denied requests for nursing and reha

Humana Inc. (NYSE: HUM) today announced that it has signed a definitive agreement with a consortium

Mizuho analyst Ann Hynes maintains Humana (NYSE:HUM) with a Outperform and raises the price targe

JP Morgan analyst Lisa Gill maintains Humana (NYSE:HUM) with a Neutral and raises the price targe

B of A Securities analyst Kevin Fischbeck maintains Humana (NYSE:HUM) with a Neutral and raises t

Morgan Stanley analyst Erin Wright maintains Humana (NYSE:HUM) with a Underweight and raises the

Truist Securities analyst David Macdonald maintains Humana (NYSE:HUM) with a Hold and raises the

Mizuho analyst Ann Hynes maintains Humana (NYSE:HUM) with a Outperform and raises the price targe

Deutsche Bank analyst George Hill upgrades Humana (NYSE:HUM) from Hold to Buy and raises the pric

Morgan Stanley analyst Erin Wright maintains Humana (NYSE:HUM) with a Underweight and raises the

https://www.cms.gov/newsroom/press-releases/cms-announces-aggressive-nationwide-crackdown-fraud-six-

ZBRA, VSTS, AMBQ, VPG, BAK, PACS, LOT, EIKN, DDD, WEN, SIBN post significant gains on better-than-ex

TD Cowen analyst Ryan Langston maintains Humana (NYSE:HUM) with a Hold and raises the price targe

JP Morgan analyst Lisa Gill maintains Humana (NYSE:HUM) with a Neutral and raises the price targe

RBC Capital analyst Ben Hendrix maintains Humana (NYSE:HUM) with a Sector Perform and raises the

Guggenheim analyst Jason Cassorla maintains Humana (NYSE:HUM) with a Buy and raises the price tar

Barclays analyst Andrew Mok maintains Humana (NYSE:HUM) with a Equal-Weight and raises the price

Evercore ISI Group analyst Elizabeth Suzuki maintains Humana (NYSE:HUM) with a In-Line and raises

Truist Securities analyst David Macdonald maintains Humana (NYSE:HUM) with a Hold and raises the

Humana stock rises after Q1 earnings beat; revenue jumps, membership surges despite profit dip and o

Humana (NYSE:HUM) FY2026 expected to be more than $9.00 vs $8.72 Est. FY2026 Revenue expected to b

Humana (NYSE:HUM) reported quarterly earnings of $10.31 per share which beat the analyst consensus e

Humana (NYSE:HUM) reported quarterly earnings of $10.31 per share which beat the analyst consensus e

Truist Securities analyst David Macdonald maintains Humana (NYSE:HUM) with a Hold and raises the

The Donald Trump administration conceded it used the wrong numbers to help launch a Medicaid fraud i

Medicare's news of a 2.48% payment rate increase for health insurers in 2027 has sparked a rally

Oil prices keep investors on the defensive. U.S. equities fell as WTI crude topped $115 on Trump&#39

A Medicare policy boost sends UnitedHealth stock and Humana higher, with ETFs emerging as key benefi

Medicare Advantage stocks surge as CMS finalizes 2027 rates. Read about the 2.48% base rate hike and

Dow Jones falls 250 points as UnitedHealth Group rises on Medicare reimbursement boost, other stocks

SILO stock rose 51.8% in pre-market trading after its PTSD treatment pipeline received a patent from

https://www.cms.gov/newsroom/press-releases/cms-finalizes-2027-medicare-advantage-part-d-payment-pol

Mark Cuban, billionaire entrepreneur and CEO of Costplusdrugs.com, praised TrumpRx, a prescription d